Moderna Affirms FY2026 Sales Guidance of $2.138B vs $2.085B Est. Revenue for 2026 FY is expected to up by 10% YoY from $1.944B.

Benzinga Newsdesk www.benzinga.com Positive 57.8%

Neg 0% Neu 0% Pos 57.8%

Moderna (NASDAQ:MRNA) affirms FY2026 sales outlook from $2.138 billion to $2.138 billion vs $2.085 billion estimate.

Comments

No comments yet. Be the first!